PNC-27
Targeted anti-cancer peptide
Longevitysubcutaneousany
Overview
Anti-cancer peptide that selectively targets cells with abnormal HDM-2 expression. Research compound for oncology applications.
Dosing
- Typical Dosage
- 2-5 mg
- Frequency
- Daily
- Cycle Duration
- Variable
- Administration
- subcutaneous
Available Vial Sizes
5mg10mg
Research compound. Inject near target areas when possible.
Comprehensive Information
AI-GeneratedGenerating comprehensive analysis...
This may take a moment
Mechanism of Action
Key Benefits
Optimal Timing
Potential Side Effects
Stacking Suggestions
Practical Tips
Could not load AI-generated information
Track Your PNC-27 Protocol
Join UpgradeYourself to track your peptide protocols, log injections with our interactive body map, and receive AI-powered insights tailored to your health goals.
Free forever planNo credit card required100+ peptides tracked